Showing 1 - 10 of 636
Persistent link: https://www.econbiz.de/10011981115
Persistent link: https://www.econbiz.de/10011983981
Persistent link: https://www.econbiz.de/10012112734
Standard measures of bodyweight (overweight and obese, for example) fail to reflect technological progress over time - and in particular, recent progress disproportionately promoting longevity at higher bodyweights (and differences in access to it). This paper builds on the pioneering work of...
Persistent link: https://www.econbiz.de/10012533362
We study the association between infectious disease prevalence and income inequality. We hypothesize that random social mixing in an income-unequal society brings into contact a) susceptible and infected poor and b) the infected-poor and the susceptible-rich, raising infectious disease...
Persistent link: https://www.econbiz.de/10014247975
Persistent link: https://www.econbiz.de/10002699879
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and a mix of Minimum Efficacy Standards and Price Controls mechanisms (MES PC). Through a...
Persistent link: https://www.econbiz.de/10013114471
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012768128
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012464081
Persistent link: https://www.econbiz.de/10008165247